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Objectives: Pregnant women present a unique challenge during this COVID-19 pandemic 40 
as they have multiple encounters with healthcare workers (HCW) and most are admitted to 41 
hospital for birth. Universal screening of this population, therefore, has several potential 42 
benefits: reducing the risk of asymptomatic transmission to HCW and other pregnant 43 
women; early patient isolation and use of appropriate personal protective equipment; and 44 
improving understanding of perinatal transmission.1,2 The prevalence of SARS-CoV-2 in 45 
pregnant women admitted for delivery in one New York hospital between March 22 and April 46 
4, 2020 was 33/215 (15.4%) and 29/33 (88%) were asymptomatic.3 Such a high proportion 47 
of asymptomatic infection was unexpected and raises questions about infection control 48 
practices in hospitals that do not routinely screen for SARS-CoV-2 in women presenting for 49 
birth. It is also not known whether this rate is generalizable to other pregnant populations.  50 
Study Design: In London, UK, pregnant women admitted to the Portland Hospital for 51 
Women and Children have been universally screened for SARS-CoV-2 using RT-PCR 52 
(nasopharyngeal swab) since March 27, 2020. The Portland Hospital provides maternity 53 
care to ~1300 women/year. During the COVID-19 pandemic, the hospital supported National 54 
Health Service maternity units by planned cesarean deliveries. Women who had a positive 55 
result and their newborns received care as per hospital protocol for COVID-19.  56 
Results: As of April 20, 2020, 129 women were tested on admission; 9 (7.0%) tested 57 
positive and 8/9 (88.9%) were asymptomatic. One symptomatic woman with fever and cough 58 
was isolated from admission and subsequently tested positive. The median age of the 59 
women was 34 years and proportion of SARS-CoV-2 positive asymptomatic pregnant 60 
women aged >34 years was 7.0% (4/57) compared to 5.6% (4/67) ≤34 years (p=0.75) 61 
(Figure). The proportion of SARS-CoV-2 asymptomatic women was 6.3% (5/79) in 62 
Caucasian, 20% (2/10) in Asian, 3.4% (1/29) in women of mixed/other ethnic origins and 63 
none of 10 Afro-Caribbean women. We assessed quintiles of deprivation based on 64 
postcode; 1/26 (3.8%) in quintile group 5 (most deprived) tested positive, compared to none 65 
in quintile group 1 (least deprived) (n=17) (P>0.05). None of the asymptomatic SARS-CoV-2 66 
positive women had co-morbidities. Only one woman had asthma and was tested negative 67 
for SARS-CoV-2. None of the positive asymptomatic women developed COVID-19 68 
symptoms or adverse perinatal outcomes (median length of stay, 2 days). All babies were 69 
well at birth and at discharge. 70 
Conclusions: In London, during the peak of the COVID-19 pandemic, 7.0% of pregnant 71 
women attending hospital for delivery were positive for SARS-CoV-2 and 8 of the 9 positive 72 
women were asymptomatic. The prevalence of SARS-CoV-2 infection was half that reported 73 
in New York: possible explanations include lower community transmission in London which 74 
did not experience the same intensity of the pandemic as New York, and differences in case 75 
mix of women attending the two hospitals, including ethnicity mix, which has been identified 76 
as a significant factor associated with risk, severity and outcomes of COVID-19.4 77 
Remarkably, though, the proportion of SARS-CoV-2 positivity women who were 78 
asymptomatic was similar between the two cohorts.3 Whilst it is reassuring that all the 79 
asymptomatic women and their babies remained well, the high proportion of asymptomatic 80 
SARS-CoV-2 positive women raises important questions about infection control and 81 
nosocomial transmission since severe disease and fatal outcomes have been reported 82 
among both HCW and some pregnant women.5 Our findings add to the growing body of 83 
evidence showing high rates of asymptomatic infection in healthcare settings and highlight a 84 
critical need for universal screening of pregnant women.  85 
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